Kenji Schorpp

2.4k total citations · 1 hit paper
42 papers, 1.5k citations indexed

About

Kenji Schorpp is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kenji Schorpp has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Kenji Schorpp's work include RNA modifications and cancer (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cell Image Analysis Techniques (5 papers). Kenji Schorpp is often cited by papers focused on RNA modifications and cancer (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cell Image Analysis Techniques (5 papers). Kenji Schorpp collaborates with scholars based in Germany, United States and Poland. Kenji Schorpp's co-authors include Kamyar Hadian, Brent R. Stockwell, Ina Rothenaigner, Peter Canoll, Pavan S. Upadhyayula, Presha Rajbhandari, Aubrianna Decker, Benjamin G. Hoffstrom, Michael E. Stokes and Kôji Uchida and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kenji Schorpp

40 papers receiving 1.5k citations

Hit Papers

Transferrin Receptor Is a Specific Ferroptosis Marker 2020 2026 2022 2024 2020 200 400 600

Peers

Kenji Schorpp
Xiao Tan China
Chandra Goparaju United States
Antje Habel Germany
Armand Bankhead United States
Daqing Wu United States
Litong Nie United States
Kenji Schorpp
Citations per year, relative to Kenji Schorpp Kenji Schorpp (= 1×) peers Wenyu Wang

Countries citing papers authored by Kenji Schorpp

Since Specialization
Citations

This map shows the geographic impact of Kenji Schorpp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Schorpp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Schorpp more than expected).

Fields of papers citing papers by Kenji Schorpp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Schorpp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Schorpp. The network helps show where Kenji Schorpp may publish in the future.

Co-authorship network of co-authors of Kenji Schorpp

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Schorpp. A scholar is included among the top collaborators of Kenji Schorpp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Schorpp. Kenji Schorpp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schorpp, Kenji, et al.. (2025). Distinct fibroblast assemblies establish scarless regeneration. Cell Reports. 45(1). 116767–116767.
2.
Schorpp, Kenji, Howard Junca, Mathias Müsken, et al.. (2024). Screening Privileged Alkyl Guanidinium Motifs under Host-Mimicking Conditions Reveals a Novel Antibiotic with an Unconventional Mode of Action. SHILAP Revista de lepidopterología. 4(8). 3125–3134. 1 indexed citations
3.
Rothenaigner, Ina, et al.. (2022). High-content screen identifies cyclosporin A as a novel ABCA3-specific molecular corrector. Klinische Pädiatrie. 234(5). 344–345.
4.
Schorpp, Kenji, Till Siebenmorgen, Kamyar Hadian, et al.. (2022). Small molecule mediated inhibition of protein cargo recognition by peroxisomal transport receptor PEX5 is toxic to Trypanosoma. Scientific Reports. 12(1). 14705–14705. 3 indexed citations
5.
Mróz, Piotr, Bettina Tippler, Kenji Schorpp, et al.. (2022). Structure-based design, synthesis and evaluation of a novel family of PEX5-PEX14 interaction inhibitors against Trypanosoma. European Journal of Medicinal Chemistry. 243. 114778–114778. 4 indexed citations
6.
Iturbide, Ane, Kenji Schorpp, Ina Rothenaigner, et al.. (2021). Retinoic acid signaling is critical during the totipotency window in early mammalian development. Nature Structural & Molecular Biology. 28(6). 521–532. 44 indexed citations
7.
Nair, Vidya Padmanabhan, Gabriele Ciceri, Johannes Jungverdorben, et al.. (2021). Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3. Cell stem cell. 28(9). 1566–1581.e8. 34 indexed citations
8.
Jagtap, Pravin Kumar Ankush, Komal Soni, Cindy L. Will, et al.. (2020). Identification of phenothiazine derivatives as UHM-binding inhibitors of early spliceosome assembly. Nature Communications. 11(1). 5621–5621. 26 indexed citations
9.
Koopmans, Tim, Pushkar Ramesh, Simon Christ, et al.. (2020). Post-surgical adhesions are triggered by calcium-dependent membrane bridges between mesothelial surfaces. Nature Communications. 11(1). 3068–3068. 60 indexed citations
10.
Braselmann, Herbert, Ines Höfig, Kenji Schorpp, et al.. (2020). Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2. Radiation Oncology. 15(1). 182–182. 3 indexed citations
11.
Dawidowski, Maciej, Kenji Schorpp, Leonidas Emmanouilidis, et al.. (2019). Structure–Activity Relationship in Pyrazolo[4,3-c]pyridines, First Inhibitors of PEX14–PEX5 Protein–Protein Interaction with Trypanocidal Activity. Journal of Medicinal Chemistry. 63(2). 847–879. 15 indexed citations
12.
Schorpp, Kenji, et al.. (2018). A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor. Journal of Biological Chemistry. 293(23). 8994–9005. 2 indexed citations
13.
Keminer, Oliver, et al.. (2017). A high-content small molecule screen identifies novel inducers of definitive endoderm. Molecular Metabolism. 6(7). 640–650. 27 indexed citations
14.
Dawidowski, Maciej, Leonidas Emmanouilidis, Konstantinos Tripsianes, et al.. (2017). Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites. Science. 355(6332). 1416–1420. 45 indexed citations
15.
Schorpp, Kenji, et al.. (2017). Innovative therapeutic modalities for solid EpCAM-positive tumours. FEBS Journal. 1 indexed citations
16.
Kirchner, Marion, Kenji Schorpp, Kamyar Hadian, & Sabine Schneider. (2017). An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system. Scientific Reports. 7(1). 7732–7732. 11 indexed citations
17.
Höfig, Ines, Michael Rosemann, Sabine Richter, et al.. (2016). Three‐dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer. Cancer Medicine. 5(4). 703–710. 22 indexed citations
18.
Diener, Susanne, Kenji Schorpp, Tim-Matthias Strom, Kamyar Hadian, & Bettina Lorenz‐Depiereux. (2015). Development of A Cell-Based Assay to Identify Small Molecule Inhibitors of FGF23 Signaling. Assay and Drug Development Technologies. 13(8). 476–487. 4 indexed citations
19.
Schorpp, Kenji & Kamyar Hadian. (2014). Small molecule Screening at Helmholtz Zentrum München – From Biology to Molecules. Combinatorial Chemistry & High Throughput Screening. 17(3). 266–271. 5 indexed citations
20.
Veen, Annemarthe G. van der, Kenji Schorpp, Christian Schlieker, et al.. (2011). Role of the ubiquitin-like protein Urm1 as a noncanonical lysine-directed protein modifier. Proceedings of the National Academy of Sciences. 108(5). 1763–1770. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026